7/18/2019 11:01:52 PM
Amgen And Allergan's MVASI And KANJINTI Now Available In US
6/28/2019 1:01:04 AM
Amgen And UCB Provide Regulatory Update On Status Of EVENITY In The EU
6/16/2019 2:10:04 AM
Amgen Announces BLINCYTO Five-Year Data; Phase 2 Single-Arm BLAST Study Shows Median Overall Survival Of 36.5 Months
6/5/2019 7:04:05 AM
Amgen Says Investigational AMG 212 Phase 1 Study Explores Use Of BiTE Platform In A Solid Tumour
6/5/2019 7:03:23 AM
Amgen Says AMG 510 First KRASG12C Inhibitor To Reach Clinical Stage After Three Decades Of RAS Research
6/3/2019 9:03:20 AM
Amgen Announces First Clinical Results From Phase 1 Study Evaluating AMG 510
6/2/2019 11:11:09 AM
Amgen Highlights Updated Phase 1 Data Of AMG 420 In Relapsed And/or Refractory Multiple Myeloma At ASCO 2019
5/29/2019 2:14:17 AM
Amgen Announces Addl Irrevocable Undertakings To Accept Recommended Public Cash Offer To Shareholders Of Nuevolution
5/22/2019 2:02:31 AM
Amgen Offers SEK 32.50 In Cash For Each Share In Nuevolution
5/2/2019 4:01:44 PM
Amgen And Syapse Announce Precision Medicine Collaboration In Oncology
4/30/2019 4:08:13 PM
Amgen Inc. (AMGN) Has Raised Its 2019 EPS Estimate To 13.25 - 14.30 From 13.10 - 14.30
4/30/2019 4:07:29 PM
Amgen Inc. (AMGN) Has Raised Its 2019 Revenue Estimate To $22.0 - $22.9 Bln From $21.8 - $22.9 Bln